Viewing StudyNCT00511108



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00511108
Status: COMPLETED
Last Update Posted: 2017-05-12
First Post: 2007-08-02

Brief Title: Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus 0431-061
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Conditions & Keywords Data

Conditions:
Name
Type 2 Diabetes Mellitus T2DM
Keywords:
Name View
Type 2 Diabetes Mellitus T2DM View